ACTRN12619000023156招募中未知
A registry of adults with active hepatitis C infection to assess the comparative effectiveness of interventions for achieving virological cure.
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •To be eligible, a participant must meet the following criteria:
- •1. Evidence of active HCV infection (HCV RNA detected) within the preceding 3 months
- •2. Adult 18 years of age or above
排除标准
- •A potentially eligible individual will be excluded from participation if either of the following criteria are met:
- •1. Already receiving direct-acting antiviral medication for HCV infection
- •2. Unable or unwilling to provide informed consent
研究者
相似试验
已完成
4 期
CHESS - Curing Hepatitis C: Effect on the Endothelium and cardiovaScular riSk - a pilot single arm trial, assessing the effect of hepatitis C virus (HCV) treatment with 12 weeks of paritaprevir/ritonavir/ombitasvir, dasabuvir +/- ribavirin on endothelial function.Hepatitis C virus infectionEndothelial functionInfection - Other infectious diseasesCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12615001167550John Hunter Hospital16
已完成
不适用
Epidemiology survey of patients with hepatitis C during hemodialysischronic hepatitis C,chronic kidney diseaseJPRN-UMIN000026677ippon Medical School Chiba Hokuso Hospital2,500
招募中
3 期
Comparison of the degree and speed of virologic response to two treatment options in patients with chronic Hepatitis C.ACTRN12615001111561Mostafa Yakoot200
招募中
不适用
Hepatitis C virus-related liver disease cohort study in KoreaCertain infectious and parasitic diseasesKCT0000306Korea Centers for Disease Control and Prevention100
已完成
2 期
A pilot phase II open-label study of oglufanide disodium in patients with chronic hepatitis CChronic hepatitis CInfection - Other infectious diseasesACTRN12607000418471Implicit Bioscience Pty Ltd17